Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Most People Who Received J&J COVID-19 Vaccine Choosing Other Vaccines For Booster Shots

    The Wall Street Journal (11/26, Loftus, Subscription Publication) reported most people who initially received the Johnson & Johnson COVID-19 vaccine are choosing other vaccines for their booster shot, according to data from the Centers for Disease Control...
    Full Article
  • Scientists Divided Over Whether COVID-19 Vaccines Or Infection Offers Stronger Immunity

    The Wall Street Journal (11/27, Roland, Subscription Publication) reported scientists are divided over how to proceed as data suggests immunity following a COVID-19 infection is as strong as immunity from vaccinations. The article said that the emergence...
    Full Article
  • WHO Projects Europe’s COVID-19 Death Toll Will Surpass 2M By Next Spring

    The New York Times (11/23, Kwai) reports, “Europe’s death toll from Covid will exceed two million people by next spring, the World Health Organization projected on Tuesday, adding that the continent remained ‘firmly in the grip of the Covid-19 pandemic.’”...
    Full Article
  • Home Testing For COVID-19 “Crucial Part” Of Staying Safe During Holiday Season, Experts Contend

    Healio (11/23, Stulpin) reports, “Experts agree that home testing for COVID-19 is a crucial part of keeping safe this holiday season.” Healio adds, “Precautionary testing may not be taken as seriously in other households this holiday season, and there are...
    Full Article
  • Atopic Dermatitis May Be Tied To Overactivity In Genes Involved In Production Of IL-4 And IL-13, Researchers Say

    Dermatology Advisor (11/23, May) reports, “Atopic dermatitis...may be associated with overactivity in genes involved in the production of interleukin 4 (IL-4) and interleukin 13 (IL-13), inflammatory immune molecules that may promote androgen production,...
    Full Article
  • Breakthrough COVID-19 Infections May Raise Risk Of Death, New Medical Conditions, Large Study Suggests

    Reuters (11/23) reports “a large study” suggests that at six months after COVID-19 infection, “people with breakthrough infections had lower rates of death and long-term lingering health problems than COVID-19 patients who had not been vaccinated.” Howeve...
    Full Article
  • Adding Ivermectin In Bird-Feeders Where Culex Mosquitoes Congregate Shows Promise In Reducing Number Of Infectious Mosquitoes That Can Transmit West Nile Virus, Research Suggests

    MedPage Today (11/23, Walker) reports, “Putting ivermectin in bird-feeders in places where Culex mosquitoes congregate showed promise in reducing the number of infectious mosquitoes that could transmit West Nile virus to humans,” according to research pre...
    Full Article
  • COVID-19 Vaccination Rates Continue To Lag Among Rural Hospital Workers Amid Ongoing Litigation

    Modern Healthcare (11/23, Kacik, Subscription Publication) reports, “COVID-19 vaccination rates continue to lag among rural hospital workers as some CEOs opt to wait for the courts to sift through conflicting state laws and federal mandates.” The article...
    Full Article
  • Justice Department Asks Appeals Court To Reinstate Administration’s COVID-19 Vaccination Or Testing Requirement For Private Businesses

    The Washington Post (11/23, Marimow) reports that on Tuesday, the Biden Administration asked the US Court of Appeals for the 6th Circuit “to reinstate its coronavirus vaccination or testing requirement for private businesses ‘as soon as possible’ and to g...
    Full Article
  • FDA Approves First Adjuvanted, Cell-Based Influenza Vaccine For Patients Six Months And Older In Event Of Pandemic

    HCPlive (11/23, Walter) reports the Food and Drug Administration “has approved a multi-dose vial (MDV) platform for Influenza A(H5N1) Monovalent Vaccine, Adjuvanted (AUDENZ) for patients 6 months and older against influenza A(H5N1) in the event of a pande...
    Full Article
  • Efforts Of National Emerging Infectious Diseases Laboratories To Prepare For Next Pandemic Highlighted

    In an essay in the New York Times Magazine (11/23), Jon Gertner writes about his visit to the National Emerging Infectious Diseases Laboratories (NEIDL), which “has one of the larger collections of Biosafety Level 4 and Biosafety Level 3 labs in the world...
    Full Article
  • Pfizer Says Its COVID-19 Vaccine 100% Effective In Adolescents Aged 12 To 15

    Reuters (11/22, Roy) reports Pfizer on Monday “said...its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15 years.” According to the company, “a two-dose series of the v...
    Full Article
  • Access To Reliable COVID-19 Testing Key To Success Of Pfizer, Merck Antiviral Treatments, Experts Say

    Kaiser Health News (11/22, Aleccia) reports that within a few weeks, “the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic – with a second option from Pfizer to follow shortly after...
    Full Article
  • Staphylococcus Aureus Remains Leading Cause Of SSTIs, Research Suggests

    Healio (11/22, Weldon) reports that “staphylococcus aureus remains the leading cause of skin and soft tissue infections, or SSTIs, according to” research that was presented “during this year’s Infectious Diseases in Children Symposium.”
    Full Article
  • Study Explores Efficacy Of PF-07321332 To Inhibit SARS-CoV-2 Main Protease

    Infectious Disease Advisor (11/22, Mermelstein) reports, “In an effort to identify inhibitors of the SARS-CoV-2 main protease (Mpro) which cleaves to polyproteins to form structural proteins that are vital for viral replication, investigators developed 7...
    Full Article
  • Ciclesonide Appears No Better Than Placebo In Alleviating COVID-19-Related Symptoms Among Nonhospitalized Patients In Trial

    Healio (11/22, Miller) reports, “Nonhospitalized patients with COVID-19 who received the inhaled glucocorticoid [ciclesonide] Alvesco had the same recovery time as those who received placebo, data from a phase 3 trial showed.” According to investigators,...
    Full Article
  • New COVID-19 Infections Rising Again As Americans Prepare For Thanksgiving

    The New York Times (11/22, 1:39 p.m. EST, Smith) reports that “as Americans travel this week” for Thanksgiving, new COVID-19 infections “are rising once more, especially in the Upper Midwest and Northeast.” The Times adds, “More than 90,000 cases are bein...
    Full Article
  • Pediatric COVID-19 Cases Have Risen 32% From Two Weeks Ago, AAP Says

    CNN (11/22, Christensen) reports, “Covid-19 cases in children are up 32% from two weeks ago, according to new numbers published Monday by the American Academy of Pediatrics.” CNN adds, “For the week ending November 18, there were at least 141,905 new case...
    Full Article
  • Vaccinating Children Against COVID-19 Helps Prevent Mutations, Asymptomatic Spread

    The AP (11/22, Ungar) reports “protecting a new, large chunk of the population anywhere in the world limits” the opportunity for new coronavirus mutations – an effort that “got a lift with 28 million U.S. kids 5 to 11 years old now eligible for child-size...
    Full Article
  • COVID-19 Interventions Led To Decrease In Rates Of Respiratory Infections In China, Researchers Say

    HCPlive (11/22, Walter) reports the byproduct of COVID-19 interventions “may have had a profound impact on the rates of other viruses like influenza, at least initially,” according to researchers who “assessed the changes in respiratory infections in Chin...
    Full Article
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id